Google's Isomorphic Labs raises over $2B for AI drug discovery

Isomorphic Labs, DeepMind's AI drug-discovery spinout, is closing a $2B+ funding round, one of the largest in applied AI biology. With active Novartis and Eli Lilly partnerships tied to AI-designed drug candidates, the raise signals institutional confidence in structure-prediction pipelines moving toward clinical pipelines.